23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › CORCEPT THERAPEUTICS INC. › 2023-2024

CORCEPT THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and CORCEPT THERAPEUTICS INC.’s Form 8-K, filed May 23, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 12Ballot items
  • 302Asset managers, any item
  • 3,690Fund votes
  • May 17, 2024Meeting date

Results at a glance

Meeting of May 17, 2024: 12 items on CORCEPT THERAPEUTICS INC.’s Form 8-K, filed May 23, 2024: 9 elected · 3 approved.

Dissent

Significant dissent: 1 equity or compensation plan (28.5% against).

Notable dissent: 1 director (13.5% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Tang Capital (13F, 1.4%, as of September 30, 2026)

Explore CORCEPT THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by CORCEPT THERAPEUTICS INC.

These tallies are CORCEPT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CORCEPT THERAPEUTICS INC. — official shareholder meeting results, meeting held May 17, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Gregg Alton 60,315,939---- 5,562,18922,496,236 92%Elected—
Elect Director: G. Leonard Baker, Jr. 62,443,392---- 3,434,73622,496,236 95%Elected—
Elect Director: Joseph K. Belanoff, M.D. 65,590,721---- 287,40722,496,236 99.6%Elected—
Elect Director: Gillian M. Cannon, Ph.D. 63,808,757---- 2,004,74022,560,867 97%Elected—
Elect Director: David L. Mahoney 64,919,195---- 958,93322,496,236 99%Elected—
Elect Director: Joshua M. Murray 65,624,110---- 254,01822,496,236 99.6%Elected—
Elect Director: Kimberly Park 56,969,410---- 8,908,71822,496,236 86%Elected—
Elect Director: Daniel N. Swisher, Jr. 65,622,142---- 255,98622,496,236 99.6%Elected—
Elect Director: James N. Wilson 62,619,695---- 3,258,43322,496,236 95%Elected—
2. Appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 86,596,5281,707,06670,770 ---- 98%Approved—
3. Compensation of named executive officers 64,501,3721,018,089358,666 --22,496,237 98%Approved—
4. Corcept Therapeutics Incorporated 2024 Incentive Award Plan 47,018,09318,698,799161,233 --22,496,239 72%Approved—

Source: CORCEPT THERAPEUTICS INC., Form 8-K, filed with the SEC on May 23, 2024 — read the filing on EDGAR.

How asset managers voted at the CORCEPT THERAPEUTICS INC. 2023-2024 meeting

302 asset managers disclosed a vote on at least one CORCEPT THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: David L. Mahoney

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 64,919,195WITHHELD: 958,933
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: David L. Mahoney

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: David L. Mahoney”): 64,919,195 for, 958,933 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 27,774,998 for, 59,126 withheld, 12,023 abstained.

FOR
FOR: 27,774,998ABSTAIN: 12,023WITHHOLD: 59,126
Largest asset managers voting on “Election of Directors: David L. Mahoney” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,552,7030 03,491For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle246,0050 00For
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions166,2770 12,0230Mixed
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).

Elect Director: G. Leonard Baker, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 62,443,392WITHHELD: 3,434,736
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: G. Leonard Baker, Jr.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: G. Leonard Baker, Jr.”): 62,443,392 for, 3,434,736 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 27,349,835 for, 484,289 withheld, 12,023 abstained.

FOR
FOR: 27,349,835ABSTAIN: 12,023WITHHOLD: 484,289
Largest asset managers voting on “Election of Directors: G. Leonard Baker, Jr.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,551,1340 05,060For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle00 0246,005Withhold
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions166,2770 12,0230Mixed
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).

Elect Director: Gillian M. Cannon, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 63,808,757WITHHELD: 2,004,740
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Gillian M. Cannon, Ph.D.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gillian M. Cannon, Ph.D.”): 63,808,757 for, 2,004,740 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 27,777,811 for, 68,336 withheld.

FOR
FOR: 27,777,811WITHHOLD: 68,336
Largest asset managers voting on “Election of Directors: Gillian M. Cannon, Ph.D.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,552,3100 03,884For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle246,0050 00For
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions178,3000 00For
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).

Elect Director: Gregg Alton

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 60,315,939WITHHELD: 5,562,189
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Gregg Alton

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gregg Alton”): 60,315,939 for, 5,562,189 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 24,497,541 for, 3,313,417 withheld, 35,189 abstained.

FOR
FOR: 24,497,541ABSTAIN: 35,189WITHHOLD: 3,313,417
Largest asset managers voting on “Election of Directors: Gregg Alton” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional00 01,618,776Withhold
State Street25,3940 01,530,800Withhold
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National259,4290 22,9420Mixed
Columbia Threadneedle246,0050 00For
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions178,3000 00For
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial36,2830 077,273Mixed
Principal104,0790 0235For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).

Elect Director: James N. Wilson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 62,619,695WITHHELD: 3,258,433
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: James N. Wilson

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: James N. Wilson”): 62,619,695 for, 3,258,433 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 27,349,835 for, 484,289 withheld, 12,023 abstained.

FOR
FOR: 27,349,835ABSTAIN: 12,023WITHHOLD: 484,289
Largest asset managers voting on “Election of Directors: James N. Wilson” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,551,1340 05,060For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle00 0246,005Withhold
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions166,2770 12,0230Mixed
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).

Elect Director: Joseph K. Belanoff, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 65,590,721WITHHELD: 287,407
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Joseph K. Belanoff, M.D.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joseph K. Belanoff, M.D.”): 65,590,721 for, 287,407 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 27,806,378 for, 39,769 withheld.

FOR
FOR: 27,806,378WITHHOLD: 39,769
Largest asset managers voting on “Election of Directors: Joseph K. Belanoff, M.D.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,553,5600 02,634For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle246,0050 00For
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions178,3000 00For
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).

Elect Director: Joshua M. Murray

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 65,624,110WITHHELD: 254,018
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Joshua M. Murray

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joshua M. Murray”): 65,624,110 for, 254,018 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 27,792,792 for, 53,355 withheld.

FOR
FOR: 27,792,792WITHHOLD: 53,355
Largest asset managers voting on “Election of Directors: Joshua M. Murray” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,553,8790 02,315For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle246,0050 00For
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions178,3000 00For
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).

Elect Director: Kimberly Park

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%
FOR: 56,969,410WITHHELD: 8,908,718
Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Kimberly Park

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kimberly Park”): 56,969,410 for, 8,908,718 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 24,058,993 for, 3,741,610 withheld, 45,544 abstained.

FOR
FOR: 24,058,993ABSTAIN: 45,544WITHHOLD: 3,741,610
Largest asset managers voting on “Election of Directors: Kimberly Park” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional00 01,618,776Withhold
State Street23,8250 01,532,369Withhold
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National259,4290 22,9420Mixed
Columbia Threadneedle00 0246,005Withhold
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions178,3000 00For
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial36,2830 077,273Mixed
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).

Elect Director: Daniel N. Swisher, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 65,622,142WITHHELD: 255,986
Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: Daniel N. Swisher, Jr.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel N. Swisher, Jr.”): 65,622,142 for, 255,986 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 27,782,792 for, 53,355 withheld.

FOR
FOR: 27,782,792WITHHOLD: 53,355
Largest asset managers voting on “Election of Directors: Daniel N. Swisher, Jr.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,553,8790 02,315For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle246,0050 00For
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions178,3000 00For
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 91 asset managers. All 91 are in the interactive database (link above).

Corcept Therapeutics Incorporated 2024 Incentive Award Plan

Official resultCOMPENSATIONReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

72% Approved · of votes cast

FOR 72%AGAINST
FOR: 47,018,093AGAINST: 18,698,799
Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: To approve the Corcept Therapeutics Incorporated 2024 Incentive Award Plan.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“4. Corcept Therapeutics Incorporated 2024 Incentive Award Plan”): 47,018,093 for, 18,698,799 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 - The Corcept Therapeutics Incorporated 2024 Incentive Award Plan was approved.”
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 19,082,904 for, 8,683,345 against.

FORAGAINST
FOR: 19,082,904AGAINST: 8,683,345
Largest asset managers voting on “To approve the Corcept Therapeutics Incorporated 2024 Incentive Award Plan.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,323,31467,600 00For
BlackRock6,720,4890 00For
First Trust01,830,396 00Against
Dimensional01,618,776 00Against
State Street10,1401,546,054 00Against
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity633,21928,791 00For
Legg Mason0417,236 00Against
Royce0331,800 00Against
Jackson National0282,371 00Against
Columbia Threadneedle0246,005 00Against
Equitable125,81794,160 00Mixed
TIAA0215,614 00Against
Janus Detroit Street Trust0202,124 00Against
ETF Series Solutions21,398156,902 00Mixed
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century0143,440 00Against
BNY Mellon0137,568 00Against
MoA Funds Corp0133,329 00Against
Lincoln Financial0113,556 00Against
Principal235104,079 00Against
AllianceBernstein098,204 00Against
Guardian Variable Products Trust093,600 00Against
Thrivent077,912 00Against

Showing the 25 largest of 91 asset managers. All 91 are in the interactive database (link above).

Compensation of named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 64,501,372AGAINST: 1,018,089
Details: description as filed, official tally, votes by 301 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“3. Compensation of named executive officers”): 64,501,372 for, 1,018,089 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 - The compensation of named executive officers was approved, on an advisory basis.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 92 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,556,1940 00For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle246,0050 00For
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions178,3000 00For
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century0143,440 00Against
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Fund voting reports, all 92 managers: 27,663,210 for, 152,298 against, 37,135 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 237 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Man Group plc10,751,9000 00For
State Street3,175,3880 00For
BlackRock2,443,498987 00For
Novo Holdings A/S2,411,3620 00For
Charles Schwab939,6620 00For
Boston Trust Walden Co762,7170 00For
Renaissance726,0460 00For
GEODE CAPITAL MANAGEMENT, LLC623,0250 00For
Northern Trust593,12955 00For
MELLON INVESTMENTS Corp586,1920 00For
PRINCIPAL GLOBAL INVESTORS526,3440 00For
Clearbridge Investments, LLC525,2670 00For
Two Sigma478,1850 00For
Cyrus J. Lawrence, LLC460,0000 00For
Cerity Partners LLC396,9410 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP338,2852,123 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC294,0980 00For
Stewart Capital Advisors, LLC269,6800 00For
Point72250,9850 00For
JACOBS LEVY EQUITY MANAGEMENT, INC243,5120 00For
Vanguard240,3390 00For
Janus Henderson219,5300 00For
Nuveen219,0370 00For
Allianz0205,284 00Against
AllianceBernstein194,7640 00For

Institutional-manager reports, all 237 managers: 32,481,298 for, 858,437 against, 5 abstained, 28,703 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 86,596,528AGAINST: 1,707,066
Details: description as filed, official tally, votes by 95 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“2. Appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024”): 86,596,528 for, 1,707,066 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 95 asset managers below reported 27,804,028 for, 13,749 against, 37,135 abstained.

FOR
FOR: 27,804,028AGAINST: 13,749ABSTAIN: 37,135
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm ” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,390,9140 00For
BlackRock6,720,4890 00For
First Trust1,830,3960 00For
Dimensional1,618,7760 00For
State Street1,555,0181,176 00For
Charles Schwab898,6960 00For
BOSTON TRUST WALDEN FUNDS763,0750 00For
Fidelity662,0100 00For
Legg Mason417,2360 00For
Royce331,8000 00For
Jackson National282,3710 00For
Columbia Threadneedle246,0050 00For
Equitable219,9770 00For
TIAA215,6140 00For
Janus Detroit Street Trust202,1240 00For
ETF Series Solutions166,27712,023 00Mixed
QUANTITATIVE MASTER SERIES LLC151,8150 00For
American Century143,4400 00For
BNY Mellon137,5680 00For
MoA Funds Corp133,3290 00For
Lincoln Financial113,5560 00For
Principal104,3140 00For
AllianceBernstein98,2040 00For
Guardian Variable Products Trust93,6000 00For
Thrivent77,9120 00For

Showing the 25 largest of 95 asset managers. All 95 are in the interactive database (link above).

Largest CORCEPT THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 103,405,000 shares outstanding at the time of that meeting.

Fund voting reports: top CORCEPT THERAPEUTICS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's named executive officers as…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 9.08%
2BlackRock 6.50%
3First Trust 1.77%
4Dimensional 1.57%
5State Street 1.50%
6Charles Schwab 0.87%
7BOSTON TRUST WALDEN FUNDS 0.74%
8Fidelity 0.64%
9Legg Mason 0.40%
10Royce 0.32%
Institutional-manager reports: top CORCEPT THERAPEUTICS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's named executive officers as…”, 2023-2024
#Asset manager % of shares outstanding
1Man Group plc 10.40%
2State Street 3.07%
3BlackRock 2.36%
4Novo Holdings A/S 2.33%
5Charles Schwab 0.94%
6Boston Trust Walden Co 0.74%
7Renaissance 0.70%
8GEODE CAPITAL MANAGEMENT, LLC 0.60%
9Northern Trust 0.57%
10MELLON INVESTMENTS Corp 0.57%

Reported CORCEPT THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

CORCEPT THERAPEUTICS INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock12,047,830 11.65%Form 13F, quarter ended March 31, 2024
Vanguard Group9,537,071 9.22%Form 13F, quarter ended March 31, 2024
Ingalls & Snyder, LLC and affiliated entities8,262,476 7.99%Proxy statement (DEF 14A), table as of April 5, 2024
Renaissance Technologies6,725,871 6.50%Proxy statement (DEF 14A), table as of April 5, 2024
Joseph K. Belanoff, M.D.6,717,334 6.50%Proxy statement (DEF 14A), table as of April 5, 2024
G. Leonard Baker, Jr.5,512,696 5.33%Schedule 13G, filed February 14, 2024
State Street3,575,526 3.46%Form 13F, quarter ended March 31, 2024
James N. Wilson3,057,093 2.96%Proxy statement (DEF 14A), table as of April 5, 2024
Dimensional Fund Advisors2,567,677 2.48%Form 13F, quarter ended March 31, 2024
FMR (Fidelity)2,201,938 2.13%Form 13F, quarter ended March 31, 2024

Percentages above are of 103,405,000 shares outstanding, as reported by CORCEPT THERAPEUTICS INC. on its Form 10-K dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At CORCEPT THERAPEUTICS INC.'s shareholder meeting held May 17, 2024, in the 2023-2024 proxy season, 302 asset managers reported votes on at least one of its 12 ballot items in their SEC Form N-PX filings, covering 3,690 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — CORCEPT THERAPEUTICS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CORCEPT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORCEPT THERAPEUTICS INC.’s 10-K dated December 31, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

CORCEPT THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “CORCEPT THERAPEUTICS (CORT) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/corcept-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.